Squarepoint Ops LLC

Position in RLMD — Relmada Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in RLMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$441,444

-$226,221 QoQ

Shares Held

63,426

-54.1% QoQ

Ownership

0.060%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Squarepoint Ops LLC holds $1,094,556,775 across 232 Biotechnology names. RLMD ranks #145 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	426,723	$141,189,839
2	REGN	Regeneron Pharmaceuticals, Inc.	162,814	$125,796,608
3	RPRX	Royalty Pharma plc	1,349,516	$64,736,282
4	IONS	Ionis Pharmaceuticals Inc	695,276	$52,208,274
5	BBIO	BridgeBio Pharma, Inc.	556,324	$41,312,620
6	MDGL	Madrigal Pharmaceuticals, Inc.	52,884	$27,683,187
7	ARQT	Arcutis Biotherapeutics, Inc.	1,103,490	$25,998,224
8	FOLD	AMICUS THERAPEUTICS, INC.	1,705,829	$24,666,287

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$441,444	63,426	-54.1%	Shares	Defined	2026-05-15
2025-12-31	$667,665	138,233	+290.2%	Shares	Defined	2026-02-13
2024-06-30	$106,275	35,425	-55.2%	Shares	Defined	2024-08-14
2024-03-31	$367,410	79,013	+7.6%	Shares	Defined	2024-05-15
2023-12-31	$304,016	73,434	+121.9%	Shares	Defined	2024-02-14
2023-09-30	$99,291	33,097	-58.1%	Shares	Defined	2023-11-14
2023-06-30	$194,389	79,020	+124.0%	Shares	Defined	2023-08-14
2022-12-31	$123,130	35,281	+394.8%	Shares	Defined	2023-02-14
2020-12-31	$228,659	7,130	-12.0%	Shares	Defined	2021-02-16
2020-06-30	$362,743	8,106	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.